These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 21868762)
1. MALT1 protease: a new therapeutic target in B lymphoma and beyond? McAllister-Lucas LM; Baens M; Lucas PC Clin Cancer Res; 2011 Nov; 17(21):6623-31. PubMed ID: 21868762 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells. Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089 [TBL] [Abstract][Full Text] [Related]
3. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions. Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209 [TBL] [Abstract][Full Text] [Related]
4. MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast. Talwalkar SS; Valbuena JR; Abruzzo LV; Admirand JH; Konoplev SN; Bueso-Ramos CE; Medeiros LJ Mod Pathol; 2006 Nov; 19(11):1402-8. PubMed ID: 16917511 [TBL] [Abstract][Full Text] [Related]
6. Protease activity of MALT1: a mystery unravelled. Kirchhofer D; Vucic D Biochem J; 2012 Jun; 444(2):e3-5. PubMed ID: 22574776 [TBL] [Abstract][Full Text] [Related]
7. MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes. Baens M; Bonsignore L; Somers R; Vanderheydt C; Weeks SD; Gunnarsson J; Nilsson E; Roth RG; Thome M; Marynen P PLoS One; 2014; 9(8):e103774. PubMed ID: 25105596 [TBL] [Abstract][Full Text] [Related]
8. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810 [TBL] [Abstract][Full Text] [Related]
9. Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad? Demeyer A; Staal J; Beyaert R Trends Mol Med; 2016 Feb; 22(2):135-150. PubMed ID: 26787500 [TBL] [Abstract][Full Text] [Related]
10. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment. Rosebeck S; Lucas PC; McAllister-Lucas LM Future Oncol; 2011 May; 7(5):613-7. PubMed ID: 21568677 [TBL] [Abstract][Full Text] [Related]
11. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Hailfinger S; Lenz G; Ngo V; Posvitz-Fejfar A; Rebeaud F; Guzzardi M; Penas EM; Dierlamm J; Chan WC; Staudt LM; Thome M Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19946-51. PubMed ID: 19897720 [TBL] [Abstract][Full Text] [Related]
12. Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas. Wimberger N; Ober F; Avar G; Grau M; Xu W; Lenz G; Menden MP; Krappmann D Blood; 2023 Dec; 142(23):1985-2001. PubMed ID: 37623434 [TBL] [Abstract][Full Text] [Related]
13. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis. Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939 [TBL] [Abstract][Full Text] [Related]
15. cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. Hu S; Du MQ; Park SM; Alcivar A; Qu L; Gupta S; Tang J; Baens M; Ye H; Lee TH; Marynen P; Riley JL; Yang X J Clin Invest; 2006 Jan; 116(1):174-81. PubMed ID: 16395405 [TBL] [Abstract][Full Text] [Related]
17. MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation. Schmitt A; Grondona P; Maier T; Brändle M; Schönfeld C; Jäger G; Kosnopfel C; Eberle FC; Schittek B; Schulze-Osthoff K; Yazdi AS; Hailfinger S J Invest Dermatol; 2016 Apr; 136(4):788-797. PubMed ID: 26767426 [TBL] [Abstract][Full Text] [Related]
18. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma. Murga Penas EM; Callet-Bauchu E; Ye H; Gazzo S; Berger F; Schilling G; Albert-Konetzny N; Vettorazzi E; Salles G; Wlodarska I; Du MQ; Bokemeyer C; Dierlamm J Blood; 2010 Mar; 115(11):2214-9. PubMed ID: 19965626 [TBL] [Abstract][Full Text] [Related]
19. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Ruland J; Duncan GS; Wakeham A; Mak TW Immunity; 2003 Nov; 19(5):749-58. PubMed ID: 14614861 [TBL] [Abstract][Full Text] [Related]
20. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies. Juilland M; Thome M Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]